Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.


TSX:SZLS - Post by User

Comment by Skrit37on Nov 25, 2020 5:25am
184 Views
Post# 31967768

RE:I poste this on another blog page

RE:I poste this on another blog pageOur board member Harry Glorikian just so happens to be co-founder of Drawbridge Health !

Nailbiter1 wrote: It brought out the sour pusses so I thought I would post it here and give the local basher brides
something to dry hump. BTW, the cushion belongs to Vlad Olteanu. He sniffs if every night.

If you look at EXAS, they are getting out of fecal testing and buying up blood diagnostics companies for the last 2 years.

Google how much they spent on these companies.

They know where the future is.

This is the closest we've been to having Aristotle available to the public. Flying under the radar right now but once we roll out, you will see commercials promoting these tests.

As phase 1 (cancer) becomes available, we are already working on other phases of detection. Our mRNA tech can be used to detect Alzheimer's, osteoporosis, Crohn's, heart disease, MS, virtually any disease. How important would it be if you could know that in 4 years from now you will have Alzheimer's or MS. Think of how you could change your life or make plans before even getting symptoms.

Exas does cancer only. Before we get to the other 4 phases of Aristotle, we have to roll out phase 1.


I can even see, at some point, our blood test evolving into a home-delivered kit, where they don't require a phlebotomist to take a vial of blood. Rather, you pick your finger with a lancet and smear a drop or two of blood on a swab and mail it to the lab for results.



<< Previous
Bullboard Posts
Next >>